Eupraxia Pharmaceuticals Inc Cash Flow Reinvestment Rate
Latest as of March 2020:
0.05x
Eupraxia Pharmaceuticals Inc cash flow reinvestment rate. Eupraxia Pharmaceuticals Inc (EPRX) has a Cash Flow Reinvestment Rate of 0.05x as of March 2020, reinvesting CA$25.31K (capex CA$3.80K plus investments CA$-21.51K) from operating cash flow of CA$503.92K. Explore Eupraxia Pharmaceuticals Inc (EPRX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.05x
(Capex + Investments) / Operating CF
Total Reinvested
CA$25.31K
Capex + Investments
Operating Cash Flow
CA$503.92K
CAD
Capital Expenditures
CA$3.80K
CAD
Eupraxia Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (None–None)
Eupraxia Pharmaceuticals Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Eupraxia Pharmaceuticals Inc. For the full cash flow conversion analysis, see EPRX cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow